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ABSTRACT
Calcusol™ is a traditional medicine (jamu) made from Tempuyung (Sonchus arvensis) extract and is 
usually used for cure kidney stone disease. However, there has not been any studies which investigate 
the its mechanism. The aim of this study is to know the effect of Calcusol™ to the plasma free radical 
and serum creatinin of Mus musculus model for renal calcium-oxalate accumulation. This study is carried 
out by administration of Porang (Amorphophallus muelleri) tuber flour for 3 months with the doses 6 
mg/100g BW to induce renal calcium oxalate accumulation and Calcusol™ treatment for 7 days with 
the doses of 3.3mg/g BW. Group I was used as a control group. Group II was only given porang every 
day for 3 months. Group III was only given Calcusol™ for 7 days. Group IV were given porang for 3 
months then given Calcusol™ for 7 days. Group V were given porang and Calcusol™ simultaneously 
for 3 months. Porang and CalcusolTM is administrated orally.  Blood was collected from the tail of the
animal for serum creatinin test and plasma free radical test using TBARS method. The data was
analyzed using ANOVA followed by Tukey HSD to compare the means employing SPSS 16.0 for
windows. The result of the research shows that the treatment Calcusol™ on mice model for renal 
calcium oxalate accumulation. The content of MDA at group I, group II, group III, group IV and 
group V, respectivelyis 0.81±0.5 mg/ml; 2.63±0.8 mg/ml; 0.56±0.5 mg/ml; 2.09±0.9 mg/ml and 
0.17±0.17 mg/ml. The content of serum creatinine are 0.15±0.04 mg/dL; 0.13±0.03 mg/dL; 0.12±0.08 
mg/dL; 0.11±0.016 mg/dL and 0.14±0.015 mg/dL at group I, group II, group III, Group IV, and 
group V respectively.  This indicates that Calcusol™ decreases plasma free radical production during 
renal stone formation, while serum creatinin reduced but not significantly changed. Calcusol™ has an 
effect to decrease free radical during renalstone formation inmice model for calcium oxalate 
accumulation and also decrease serum creatinin.
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INTRODUCTION
Nephrolithiasis (kidney stone disease) is one 
of the diseases that is characterized by calcium 
deposits in kidney especially in renal tubules, 
pelvis, ureter and urinary bladder [1]. The 
number of kidney stone disease cases has 
increased in the last five decades in this world. 
Most of kidney stone is caused by calcium 
oxalate accumulation [2]. Kidney stone formation
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consists of several stages including supersatu-
ration, nucleation, growth, aggregation, and 
retention within renal tubules [3].
Urine supersaturation condition allows for 
interaction between oxalate and renal tubular 
cells, that can lead to cell damage caused by free 
radical or reactive oxygen species (ROS) 
activities. The formation of free radicals due to 
the interaction between oxalate and renal tubular 
cells will result in some lipid signaling that is 
responded by mitochondrion with the increase of 
free radical [4]. The increase of free radicals is 
followed by the increase of lipid peroxidation 
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product, malondyaldehyde (MDA), and the de-
crease of antioxidant enzyme activity such as 
SOD, catalase, and GPx [5]. The involvement of 
free radicals at the calcium oxalate accumulation 
creates cell debris of dead cells for nucleation 
that triggers calcium oxalate accumulation [6]. 
The presence of calcium oxalate in kidney that 
caused by administration of porang (A. muelleri) 
tuber flour can trigger an increase of MDA in 
kidney, in which thin free radicals cause cell 
damage characterized by necrosis [7, 8]. This 
accumulation also increases the plasma and hepar 
of MDA [9].  
Calcium oxalate accumulation in the kidney 
also affects blood and urine creatinine level, in 
which calcium oxalate accumulation can increase 
blood creatinine level, and decrease urine 
creatinine level. However, treatment using herbal 
agent that contains antioxidants can reduce blood 
creatinine level and increase urinary creatinine 
levels in mice with accumulate calcium oxalate 
level [2]. This suggests that creatinine may be 
associated with renal physiology function [10].
Individuals who have formed a kidney stone 
are more likely to form another, so we need a 
treatment to prevent formation of another 
stones. Treatment using herbal agent to break 
down kidney stones is suggested since the 
medicine has no side effect. Calcusol™ is a 
traditional medicine or jamu that has been used 
to break down kidney stones. Calcusol™ is made 
from tempuyung (Sonchus arvensis) leave extract. 
However, the cellular mechanisms of decaying 
kidney stones remain unknown. Based on the 
research by dr. Sardjito (1964), the action of 
Calcusol™ goes directly on kidney stones. 
However, the mechanism of Calcusol™ action 
on breaking down kidney stones is still unknown. 
Therefore, in this study we want to examine the 
physiological mechanism of Calcusol™ in 
reducing kidney stones. In the present study, we 
examine the way Calcusol™ decreases plasma 
MDA or free radicals and blood creatinine levels 
of mice (Mus musculus) induced with calcium 
oxalate accumulation.
MATERIALS AND METHODS
Mouse Model Induced by CaOx accu-
mulation
This experiment used mice (Mus musculus) 
asthe animal model. Twenty-five Swiss male mice
(8 weeks old), weighing 25-30 g were divided 
into5 groups, each group consisted of 5 mice. 
Mice were obtained from LPPT Gajah Mada
University. To induce CaOx accumulation in
mice, porang (A. muelleri) was orally adminis-
trated in mice for 3 month with doses of 
6mg/100 g BW [8]. The occurrence of 
nephrrolithiasis is characterized by calcium ox-
alate accumulation in kidney.
Calcusol™ Treatment
The animals were divided into 5 groups.
Group I was as a control. Group II was orally 
given porang every day for 3months. Group III 
was given Calcusol™for 7 days. Group IV were 
given porang for 3 months then given Calcusol™
for 7 days. Group V were given porang (A. 
muelleri) and Calcusol™ simultaneously for 
3months. Calcusol™ were orally given to mice at 
doses3.3 mg/g BW for 7 day.
Serum Creatinine Assay
At the end of experiment, blood was taken 
from tail mice, and then put in a tube eppendof. 
Blood samples were incubated at 37˚Cfor 30 
minutes and centrifuged at 7500 rpm for 10 
minutes at 4˚C. Supernatant was used for 
creatinine assay in Saiful Anwar Hospital Malang 
by enzymatic method using Kobas 501 Kit.
Measurement Plasma Free Radical using 
TBARS Method
Malondyaldehyde (MDA) content was
determined using thiobarbituric acid reactive
(TBARS) method [2]. Mice blood was centrifuged 
at 7250 rpm. Plasma were taken as 100 μL and 
dissolved in 900 μL tris buffer pH 7 and added 
50 μL TCA 100% and 125 μL of 1N HCl. The 
samples were centrifuged at 1800 rpm for 20 min 
at 4˚C. The supernatant was added 50 μL Na-
Thio 1, incubated 100 ˚ C for 30 minutes using
water bath, then cooled in room temperature.
The samples were measured at a wavelength of
maximum absorbance (533 nm) using spectropho
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tometer UV-Vis.
Analysis Data
The data was analyzed using a test of 
variance (ANOVA) technique with P<0.05 and 
the Tukey.  HSD test was used to compare the 
means. All the tests employed SPSS 16 for 
windows.
RESULTS AND DISCUSSION
MDA is one of lipid peroxidation products 
that is usually used as a biomarker of oxidative 
stress in the cells. Figure 1 shows statistically 
significant reduction of plasma MDA level at the 
Calcusol™ treatment to control group. The 
contents of MDA are 0.81±0.5 mg/ml; 2.63±0.8 
mg/ml; 0.56±0.5 mg/ml; 2.09±0.9 mg/ml and 
0.17±0.17 mg/ml in group I, group II, group II, 
group IV, and group V, respectively. There is no 
significant difference of MDA level at group V, 
group II and group I.
From this result, it is known that the 
treatment of Calcusol™ on mice model of 
calcium oxalate accumulation can reduce MDA 
(malondyaldehyde) as an indicatorof stress oxi-
dative in cells caused by lipid peroxidation. 
Figure 2 shows the blood creatinine level at 
allgroups in this experiment. The levels of blood 
creatinine are 0.15±0.04 mg/dL; 0.13±0.03 
mg/dL; 0.12±0.08 mg/dL; 0.11±0.016 mg/dL 
and 0.14±0.015 mg/dL in group I, group II, 
group II, group IV, and group V respectively. 
There was no significant increase in the blood 
creatinine levels between all groups.
The oxalate induced membrane peroxidation
leads to membrane integrity loss, renal cell
damage and finally, calcium oxalate crystal
deposition. In this study, the Calcusol™ 
treatment decreased the lipid peroxidation and 
reversethe effects of oxalate on oxidative stress
parameters. Accumulation of calcium oxalate in 
the body, especially in kidneys [11], such as 
porang (A. muelleri) consumption tuber flour for 
a long time (three months) may cause calcium 
oxalate accumulation in kidneys and also increase 
of free radicals [8]. Before entering the kidneys, 
calcium oxalate will be absorbed by the intestinal 
cells, and intact through passive transport 
pathways, and further carried by the blood 
circulatorysystem and further carried by the 
blood circulatory system [12]. When calcium 
oxalate enters kidneys, the activity of oxalate 
binding protein will increase. This protein plays 
role in the nucleation process in the kidneys 
crystallization [3]. This condition generates 
interaction between oxalatewith renal cells. 
Besides that, urine supersaturation condition 
allows for interaction between oxalate and renal 
tubular cells that leads to crystallization process. 
The super saturation urine is a condition in 
which urine have high amount of calcium, 
phosphate, and oxalate will cause the formation 
of calcium oxalatecrystal. Thus, the oxalate 
crystal will bind therenal tubules cell and generate 
interaction between renal tubular cells and 
oxalate [13].
Exposure to oxalate elicits will cause changes 
inrenal plasma membrane that can lead to 
cellinjury including endocytosis and retribution 
of phosphatidylserine membrane from the inner
layers of the cells to the surface of the cells. This
condition promotes crystal attachment to 
therenal cell. The interaction between oxalate 
andrenal tubular cells, leading to membrane 
changing include endocytosis of crystal and 
retribution of phosphatidylserine generating lipid
signaling. This signaling will be responded by 
the mitochondria with the increase of ROS and 
cytochrome C, reduced GSH activity, and 
decrease potential membrane. The net responseto 
oxalate exposure can be cell death orapoptosis 
[14]. 
Free radicals are one of the molecules having 
free electron, and are generally short lived, and 
thus inflict damage only in the local environment 
where they are produced. The cytotoxic 
aldehydes are extremely active; they can diffuse 
within or even escape from the cell and attack 
targets far from the site of the original free 
radical initiated vent, resulting in cell damage 
[15]. Malondialdehyde (MDA) is a product of 
lipid peroxidation and its measurement serves as 
an indicator of free radical damage. From 
theanalysis of this experiment, high level of 
MDA is seen only in nephrolithiasis mice. This 
suggests that the potential ability of Calcusol™ 
to reduce the greater impact of free radical 
damage by interacting with hydroxyl radical and 
enhancing the suppression of free radical 
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mediated lipid peroxidation. Free radicals are 
produced in kidney will diffuse into the blood 
vessels. Thus, the content of MDA in the mice 
blood is high by the accumulation of calcium 
oxalate compared with controls. [9] Suggests that 
the accumulation of calcium oxalate that caused 
by the consumption of porang tuber can increase
the MDA level of blood plasma. In other studies,
it is also noted that increasing levels of MDA will
happen not only in the kidney, but also in the
blood plasma [16, 17]. However, the Calcusol™
treatment can reduce free radicals, characterized
by the decrease of MDA levels compared with
mice that accumulate calcium oxalate (p < 0.05).
Calcusol™ is possible to have antioxidant that
can neutralize free radicals formed in the kidney 
because Calcusol™ is made from herbal agent of
Tempuyung (Sonchus arvensis) extract. 
The assumption of oxidative stress as a 
mechanism inoxalate induced renal damage 
suggests that antioxidants might play a beneficial 
role against oxalate toxicity. Creatinine is one of 
breakdown product from creatin. At the normal 
condition, creatinine will be discarded from the 
body by the kidneys through urine. When the 
physiological function of kidney impaired, the 
renal creatinine will be distributed in the blood. 
So, the level of creatinine in the blood will 
increase [10]. This indicates that blood creatinine 
levels describe the physiological function of the 
kidney. Plasma or serum creatinine is the 
routinely used marker for the assessment of renal 
function [18]. Super saturation of urine with 
CaOx, the most common component of kidney 
stones is an important factor in crystallization 
[19] and enhanced urinary creatinine levels are 
indicators of renal impairment [20]. In the 
present study, porang tuber administration does 
not show such significant difference between all 
group sincluding the treatment using Calcusol™.
However, in other studies, rat on ethylene glycol
administration experience an increase in the level
of creatinine [21]. Other studies show that
glyoxylate administration at mice is capable to
increase blood creatinine levels and also reduce
urine creatinine level. The accumulation of
calcium oxalate in the kidneys causes a decrease
in the physiological function, and affects the
metabolism of creatinine in the body. This
suggests that the accumulation of calcium oxalate
influences kidney physiological condition 
increatinine clearance. When creatinine is 
excreted in the urine should actually be 
distributed in the blood resulting in decreasing 
urine creatinine levels. Nevertheless, the 
treatment with herbs can be seen as an effort to 
prevent the formation ofcalcium oxalate 
accumulation in kidneys which can restore 
creatinine level to it’s the original state [2].
CONCLUSIONS
Calcusol™ can decrease free radical levels
during renal stone formation in mice model of 
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Figure 1. Malondyaldehyde content after supplemented 
with Calcusol™
Figure 2. Creatinine Level after supplemented with 
Calcusol™
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calcium oxalate accumulation. It is characterized 
by the decrease of MDA levels. This suggests 
that the potential ability ofCalcusol™ is to 
reduce the greater impact of free radical damage. 
Calcusol™ ispossible to have antioxidant that 
can neutralize free radicals formed in the kidney, 
because Calcusol™ is made from herbal agent of
Tempuyung (Sonchus arvensis) extract. There was
no significant increase in the blood creatinine
levels between all groups in the experiment.
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